Research Publications

Zhang J, Qian S, Su G, Deng C, Reid D, Sinclair B, Yu P (2024). Investigating the Service Utilisation and Pathways of Patients with Alcohol Use Disorders. Alcohol and Alcoholism. 59(6), agae075.

*Dunn A, Wu N, Cordaro F (2024). Management of loperamide-related opioid use disorder with buprenorphine within an Australian context: A case report. Drug and Alcohol Review, 43(6), 1645-1648

McKetin R, Degan T, Saunders L, Nguyen L, Dore G, Shoptaw S, Farrell M, Degenhardt L, Kelly P, Turner A, Clare P, Dean O, Arunogiri S, Colledge-Frisby S, Koeijers J, Goodman-Meza D, Sinclair B, Reid D, Hill H, Hayllar J, Christmass M, Cordaro F, Lundin R, Liaw W, Liu D, Holyoak E, Wu B, Keygan J, Kontogiannis A, Palmer L, Morrison C, Wrobel A, Hyland B, Byrne M, Russell S, Zahra E, Berk M (2024). A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial. Trials, 25, Article number: 408.

Broady T, Valerio H, Alavi M, Wheeler A, Silk D, Martinello M, Conway A, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore G, Treloar C, Grebely J; ETHOS Engage Study Group (2024). Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs. International Journal of Drug Policy, 128,104468.

Heijstee N, Black El, Black Em, Demirkol A, Mammen K, Mills L, Deacon R, Ezard N, Montebello M, Reid D, Bruno R, Shakeshaft A, Siefried K, Farrell M, Lintzeris N (2024). Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia. Journal of Addiction Medicine. Epub ahead of print. PMID: 38828937.

*Cordaro F, Qian S, Sinclair B (2023). Investigating hepatitis C screening among people receiving opioid agonist treatment: A retrospective audit study. Journal of Infection Prevention.

Black E, Bruno R, Mammen K, Mills L, Siefried K, Deacon R, Shakeshaft A, Dunlop A, Ezard N, Montebello M, Childs S, Reid D, Holmes J, Lintzeris N (2023). Substance use, socio‐demographic characteristics, and self‐rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study. Medical Journal of Australia, 219(5), 218-226.

Monds L, Topp L, Pados J, Holmes J, Lintzeris N (2023). The DACRIN data project: A process for harmonising data collection for clinical research in alcohol and other drugs services in New South Wales. Drug and Alcohol Review, 42(6), 1433-1426.

Black E, Mammen K, Deacon R, Ezard N, Mills L, Dunlop A, Montebello M, Reid D, Childs S, Bruno R, Shakeshaft A, Siefried K, Farrell M, Holmes J, Lintzeris N (2023). Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and Alcohol Review, 42(2), 389-400.

Carter G, Spittal MJ, Glowacki L, Gerostamoulos D, Dietze P, Sinclair B, Arunogiri S, Berk M, Lubman DI, Manning V, Higgs P, Quinn B, Baker A, Dean OM, Turner A, McKetin R . Diagnostic accuracy for self-reported methamphetamine use versus oral fluid test as the reference standard, in a methamphetamine dependent intervention trial population. Addiction 2022, 118(3): 470-479. https://doi.org/10.1111/add.16085

Conway A, Valerio H, Alavi M, Silk D, Treloar C, Hajarizadeh B, Marshall AD, Martinello M, Milat A, Dunlop A, Murray C, Prain B, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Christmass M, Wade A, Montebello M, Dore GJ, Grebely J on behalf of the ETHOS Engage Study Group. A testing campaign intervention consisting of peer-facilitated engagement, point-of-care HCV RNA testing, and linkage to nursing support to enhance hepatitis c treatment uptake among people who inject drugs: The ETHOS Engage Study. Viruses 2022, 14(7): 1555. https://doi.org/10.3390/v14071555

Valerio H, Alavi M, Conway A, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Grebely J, on behalf of the ETHOS Engage Study Group. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: the ETHOS Engage Study. International Journal of Drug Policy 2022, 105:103706. https://doi.org/10.1016/j.drugpo.2022.103706

Zhang J, Qian S, Su G, Deng C, Reid D, Curtis K, Sinclair B, Yu P. Emergency department presentations of patients with alcohol use disorders in an Australian regional health district, Substance Abuse 2022, 43:1, 1126-1138. https://doi.org/10.1080/08897077.2022.2060427

*Graf C, Qian S, Viret N, Lautier A. Knowledge and experience of using performance and image enhancing drugs among attendees of a Needle and Syringe Program in Australia: A qualitative study. Performance Enhancement & Health 2022, 10(2): 100222. https://doi.org/10.1016/j.peh.2022.100222

MacPhail C, Stratten M. Sexual health in a new cultural context: a resource for international students in regional Australia. Health Promotion International 2022, daab212. https://doi.org/10.1093/heapro/daab212

Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Treloar C, Dore GJ, Grebely J: Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. International Journal of Drug Policy 2021, 96: 103421. http://dx.doi.org/10.1016/j.drugpo.2021.103421

McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Sinclair B, Reid D, Baker AL, Manning V, Pas Nt, Thomas T, Bathish R, Raftery DK, Wrobel A, Saunders L, Arunogiri S, Cordaro F, Hill H, Hall S, Clare PJ, Mohebbi M, Berk M: N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial. EClinicalMedicine 2021, 38:101005.  https://doi.org/10.1016/j.eclinm.2021.101005

*Qian S, Munyisia E, Reid D, Hailey D, Pados J, Yu P. Trend in data errors after the implementation of an electronic medical record system: A longitudinal study in an Australian regional Drug and Alcohol Service. International Journal of Medical Informatics 2020. 

McKetin R, Quinn B,  Higgs P, Berk M, Dean OM, Turner A, Kelly PJ, Lubman DI, Carter G, Baker AL, Manning V, Thomas T, Bathish R, Raftery D, Saunders L, Wrobel A, Meehan A, Sinclair B, Reid D, Arunogiri S, Hill H, Cordaro F, Dietze P.  Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: findings from a pharmacotherapy trial. Drug and Alcohol Review 2020.

Raftery D, Kelly P, Deane F, Baker L, Ingram I, Goh M, Lubman D, Carter G, Turner A, Dean O, Sinclair B, McKetin R: Insight in substance use disorder: A systematic review of the literature. Addictive Behaviors. 2020;111:106549. 

Valerio H, Alavi M, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Holden J, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Dore G and Grebely J (2020). Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study. Clinical Infectious Diseases 2020. 

tudents connecting with a sexual health and relationships information kit. 31st ISANA Conference.

*Qian S, Irani M, Brighton R, Yeo W, Reid D, Sinclair B, Bresnahan S, Lynch P, Feng X, Yu P: Investigating the management of alcohol-related presentations in an Australian teaching hospital. Drug and Alcohol Review 2019, 38(2):190-197.

McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Baker AL, Sinclair B, Reid D, Manning V, te Pas N, Liang W, Thomas T, Bathish R, Kent M, Raftery D, Arunogiri S, Cordaro F, Hill H and Berk M: A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence. Trials 2019, 20(1):325.  

Davis EL, Kelly PJ, Deane FP, Baker AL, Buckingham M, Degan T, Adams S: The relationship between patient-centered care and outcomes in specialist drug and alcohol treatment: A systematic literature review. Substance Abuse 2019:1-16. 

*Munyisia EN, Reid D, Yu P: Accuracy of outpatient service data for activity-based funding in New South Wales, Australia. Health Information Management Journal 2017, 46(2):78-86.  

White B, Black E, Haber P, Whitton G, Graham R, Tracy M, Ezard N, Reid D, Childs S, Theodorou S, Lagios K, Leigh L, Nolan E, Luksza J, Qian S, Smylie C, Roberts J, Lintzeris N, Dunlop A (2024). What can community opioid treatment programs data tell us about the impact of long-acting depot buprenorphine on the high-risk post-release period for people with opioid dependence? Drug and Alcohol Review, 43(S1)

Lawson S, Pazeski A, White B, Peck L, Whitton G, Tracy M, Ezard N, Reid D, Childs S, Theodorou S, Lagios K, Luksza J, Lokuge B, Roberts J, Haber P, Lintzeris N, Dunlop A, Maher L (2024). Exploring barriers and enablers of long-acting injectable buprenorphine in a post-release patient population: Community opioid treatment program staff perspectives. Drug and Alcohol Review, 43(S1)

*Stratten M, Basheer E, Devkota A, Vu G (2023). Meeting sexual and reproductive health needs for international students through a whole of program consultative approach. Australian & New Zealand Student Services Association (ANZSSA) Conference 2023. Western Sydney University, Parramatta, 18-20 October 20 2023.

*Stratten M, Basheer E, Devkota A, Vu G (2023). Meeting sexual and reproductive health needs for international students through a whole of program consultative approach. SEXtember 2023: The Sex, Health and Society Conference. University of New South Wales, Sydney, 25-27 September 2023.

Keygan J, Palmer L, Degan T, Saunders L, Hayllar J, Sinclair B, Reid D, Cordaro F, Kelly P, Christmass M, Hill H, Lundin R, Turner A, Dean O, Berk M, Dore G, Shoptaw S, Goodman-Meza D, Philip Clare, Arunogiri S, Colledge-Frisby S, Koeijers J, Morrison C, Wrobel A, Thomas T, Hatton E, Farrell M, Degenhardt L, McKetin R (2023). The Tina trial: Progress of a phase 3 randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine (“ice”) dependence. Drug and Alcohol Review, 42(S1).

*Qian S, Abdo J, Adams S, Bowles K, Whiting R, Larance B, Nguyen N (2023). Evaluation of videos for family members and friends of people with alcohol or drug concerns, Drug and Alcohol Review, 42(S1).

*Riordan V, Seddon S, Qian S (2023). Examining the documentation of alcohol use in maternal records of SUPPS clients who identify alcohol as the primary substance of concern, Drug and Alcohol Review, 42(S1).

Zhang J, Qian S, Su G, Deng C, Reid D, Sinclair B, Yu P (2023). Investigating pathway patterns of patients with alcohol use disorders: A process mining approach, Drug and Alcohol Review, 42(S1).

Haynes C, Lunn J, Adams S, Berry J, Bliokas V, Qian S, Kelly P (2023). Feasibility and preliminary efficacy of online delivery of the cognitive enhancement program in a community outpatient setting for people who use methamphetamines. Drug and Alcohol Review, 42(S1).

Parvaresh L, Mills L, Dunlop A, Jamshidi N, Tracy M, Baker K, Tremonti C, Lintzeris N (2023). Australian Opioid Treatment Program staff perspectives regarding cannabis use by clients on opioid agonist treatment: A cross-sectional survey. Drug and Alcohol Review, 42(S1).

*Farinella J (2023). Condom dispenser project. Australasian Sexual and Reproductive Health Alliance Conference 2023. Manly Pacific, Sydney 18-20 Sep 2023.

*Farinella J (2023). On the couch webinars. Australasian Sexual and Reproductive Health Alliance Conference 2023. Manly Pacific, Sydney 18-20 Sep 2023.

*Farinella J (2023). Surfboard Campaign - getting on board with sexual health promotion. Australasian Sexual and Reproductive Health Alliance Conference 2023. Manly Pacific, Sydney 18-20 Sep 2023.

*Middleton K (2023). Co-design of the youth empowerment tool. Australasian Sexual and Reproductive Health Alliance Conference 2023. Manly Pacific, Sydney 18-20 Sep 2023.

*Stratten M (2023). Digital sexual health promotion: Website evaluation. Australasian Sexual and Reproductive Health Alliance Conference 2023. Manly Pacific, Sydney 18-20 Sep 2023.

*Viret N (2023). Sexual and reproductive health education and chlamydia screening for high school students in an out of school setting. Australasian Sexual and Reproductive Health Alliance Conference 2023. Manly Pacific, Sydney 18-20 Sep 2023.

*Viret N (2023). Incorporating trauma informed practice into rural health settings through the demonstration of an online resource. Inaugural Shoalhaven Rural Health Research Conference. 18 March 2023.

Graf C, Qian S, Hampson A, Lautier A, McAlister P, Reid D (2023). Hepatitis C Point of Care Testing outreach model in a Drug and Alcohol Service. 1st Australasian Conference on Point of Care Testing for Infectious Diseases (POC 2023). Sheraton Grand Sydney Hyde Park Tuesday 14 - Wednesday 15 March 2023.

*Viret N. Online Trauma Informed Sexual Health Training for Foster Carers. NSW Health Youth and Well-Being and Health In-reach Nurse Conference 2022.

Stowe M, Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Amin J, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall A, Dore G, Treloar C, Grebely J. Increased access to naloxone among people who inject drugs or received opioid agonist treatment, including those who have experienced recent non-fatal opioid-related overdose in Australia. International Network on Health and Hepatitis in Substance Users (INHSU) Conference 2022.

Broady T, Valerio H, Alavi M, Wheeler A, Silk D, Martinello M, Conway A, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore G, Treloar C, Grebely J. Factors associated with stigma, discrimination, and negative health care treatment among people who inject drugs: The ETHOS Engage Study. International Network on Health and Hepatitis in Substance Users (INHSU) Conference 2022.

*Qian S, Seddon S, Cowman J. Antenatal care engagement among pregnant women who identify methamphetamine as the primary substance of concern, Drug and Alcohol Review 2022, 41 (S1).

*Qian S, Abdo J, Adams S, Bowles K, Whiting R, Larance B, Nguyen N. Development of a video for families and friends of people with alcohol or drug concerns, Drug and Alcohol Review 2022, 41 (S1).

*Cordaro F, Qian S, Sinclair B. A baseline assessment of the hepatitis C virus screening rate of patients enrolled at an opioid agonist treatment clinic before the COVID-19 pandemic, Drug and Alcohol Review 2022, 41 (S1).

Mills L, Mammen K, Deacon R, Black E, Montebello M, Bruno R, Dunlop A, Ezard N, Shakeshaft A, Farrell M, Holmes J, Reid D, Childs S, Siefried K, Lintzeris N. Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data, Drug and Alcohol Review 2022, 41 (S1).

Larance B, Garton A, Hatton E, Haynes C, Rushton C, Lago L, Adams S, Robinson L, Lappin J, Reid D, Kelly P. A systematic review of brief interventions for psychostimulant use in primary and acute care settings, Drug and Alcohol Review 2022, 41 (S1).

Black E, Mammen K, Deacon R, Mills L, Montebello M, Bruno R, Dunlop A, Ezard N, Shakeshaft A, Farrell M, Holmes J, Reid D, Childs S, Siefried K, Lintzeris N. Clients entering New South Wales alcohol and other drug treatment services: Characteristics by principal drug of concern, July 2016–2019, Drug and Alcohol Review 2022, 41 (S1).

Davis S, Qian S, Cordaro F. Blood and demographic profiles of inpatients undergoing assisted alcohol detoxification and impact on hospital readmissions and length of stay. Internal Medicine Journal 2022, 52 (S4).

*Viret N, van Ritten J, Avasalu R. Online Trauma Informed Sexual Health Training for Foster Carers. Joint Australasian HIV&AIDS + Sexual Health Conferences 2022.

*Stratten M, Devkota A, Slattery C, Avasalu R. Connecting international students with online sexual and reproductive health Information. Joint Australasian HIV&AIDS + Sexual Health Conferences 2022.

*Farinella J, Stratten M, Viret N. Digital sexual health promotion in a pandemic. Joint Australasian HIV&AIDS + Sexual Health Conferences 2022.

*Seddon S, Qian S, Kunjunju A. Opioid use during pregnancies and the management and outcomes for opioid exposed newborns of clients of the Substance Use in Pregnancy and Parenting Service. Journal of Paediatrics and Child Health 2022, 58(S2).

*Stratten M. A new kind of passport: A co-created sexual health resource for international students. Enhancing Practice 2022.

*Qian S, Seddon S: Hospital admission for vomiting among pregnant women who self-reported non-medicinal cannabis use. Drug and Alcohol Review 2021, 40(S1):S121.

*Qian S, Woods D, Nguyen N, Bowles K, Whiting R, Adams S, Larance B: Enhancing access to support serviecs for families and friends of people with alcohol or drug concerns; barriers, facillitators and recommendations. Drug and Alcohol Review 2021, 40(S1):S121

Larance B, Lago L, Moules S, Adams S, Qian S, Robinson L, Lappin J, Reid D, Kelly P: Patterns of mental health and alcohol and other drug service use after attending emergency department with an amphetamine-related presentation. Drug and Alcohol Review 2021, 40(S1): S94.

Mcketin R, Dean OM, Turner A, Kelly P, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Sinclair B, Reid D, Baker AL, Manning V, te Pas N, Thomas T, Bathish R, Raftery D, Wrobel A, Saunders L, Arunogiri S, Cordaro F, Hill H, Hall S, Clare PJ, Mohebbi M, Berk M: Predicting reductions in methamphetamine use in the N-ICE trial: a randomised controlled trial of N-acetyl cysteine for methamphetamine dependence. Drug and Alcohol Review 2021, 40(S1): S12.

Mcketin R, Dean OM, Turner A, Kelly P, Quinn B, Lubman DI, Dietze PM, Carter G, Higgs P, Sinclair B, Reid D, Baker AL, Manning V, te Pas N, Thomas T, Bathish R, Raftery D, Wrobel A, Saunders L, Arunogiri S, Cordaro F, Hill H, Hall S, Clare PJ, Mohebbi M, Berk M: Findings of the N-ICE study: a randomised controlled trial of the safety and efficacy of N-acetyl cysteine as a pharmacotherapy for methamphetamine dependence. Drug and Alcohol Review 2021, 40(S1): S105.

Monds LA, Topp L, Pados J, Holmes J, Hutchinson S, Hudson S, Lintzeris N: The DACRIN Data Project: A process for harmonising data collection across AoD services in NSW. Drug and Alcohol Review 2021, 40(S1): S109.

Heijstee N, Black E, Black E, Demirkol A, Mills L, Deacon RM, Mammen K, Dunlop A, Ezard N, Montebello M, Reid D, Childs S, Lintzeris N: Who we are helping: describing demographic, health and social factors associated with principal drug of concern, alcohol use and alcohol-related harms, in the Australian alcohol and other drug treatment-seeking population. Drug and Alcohol Review 2021, 40(S1): S79.

Valerio H, Alavi M, Conway A, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Montebello M, Burns C, Wade A, Dore GJ, Grebely J, on behalf of the ETHOS Engage Study Group: Declining prevalence of current HCV infection associated with increased treatment uptake among people who inject drugs: the ETHOS Engage Study. Drug and Alcohol Review 2021, 40(S1): S146.

Black E, Deacon R, Mills L, Mammen K, Dunlop A, Ezard N, Montebello M, Bruno R, Shakeshaft A, Farrell M, Holmes J, Reid D, Childs S, Siefried KJ, Cretikos MA, Lintzeris N: Starting treatment in public drug and alcohol services in New South Wales: what can electronic medical records tell us about amphetamine type stimulant use? Drug and Alcohol Review 2021, 40(S1): S48.

Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod ME, Henderson C, Read P, Gilliver R, Amin J, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Dore GJ, Treloar C, Grebely J, on behalf of the ETHOS II Study Group: Opioid overdose and naloxone access among people who recently used opioids or received opioid agonist treatment in Australia: the ETHOS Engage study. Drug and Alcohol Review 2021, 40(S1): S59.

*Stratten M: International Student Health Hub. 25th Australian and New Zealand Student Services Association (ANZSSA) Conference 2021.

*Stratten M, Devkota A: Connecting international students with sexual & reproductive health information. 32nd ISANA International Education Association Conference 2021.

Valerio H, Alavi M, Conway A, Silk D, Treloar C, Martinello M, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Montebello M, Burns C, Wade A, Dore GJ, Grebely J, on behalf of the ETHOS Engage Study Group: Declining prevalence of current HCV infection associated with increased treatment uptake among people who inject drugs: the ETHOS Engage Study. International Network on Health and Hepatitis in Substance Users (INHSU) Conference 2021.

Wheeler A, Valerio H, Cunningham EB, Martinello M, Matthews G, Colledge S, Alavi M, Amin J, Dunlop A, Gorton C, Hayllar J, Henderson C, Holden J, Lam T, Marks P, Milat A, Read P, Reid D, Silk D, Treloar C, Degenhardt L, Dore GJ, Grebely J, on behalf of the ETHOS Engage Study Group: Prevalence and factors associated with hospitalisation for drug-related causes among people who inject drugs: the ETHOS Engage study. International Network on Health and Hepatitis in Substance Users (INHSU) Conference 2021.

Conway A, Valerio H, Peacock A, Degenhardt L, Hayllar J, Harrod M, Henderson C, Read P, Gilliver R, Amin J, Christmass M, Dunlop A, Montebello M, Whitton G, Reid D, Lam T, Alavi M, Silk D, Marshall AD, Dore GJ, Treloar C, Grebely J, on behalf of the ETHOS II Study Group: Opioid overdose and naloxone access among people who recently used opioids or received opioid agonist treatment in Australia: the ETHOS Engage study. International Network on Health and Hepatitis in Substance Users (INHSU) Conference 2021.

Zhang J, Qian S, Su G, Deng C, Yu P: Predictors of readmission following hospital treatment for patients with alcohol related diagnoses in an Australian regional health district. World Congress on Medical and Health Informatics (MedInfo) 2021.

*Qian S, Seddon S: Investigating hospital admission for the management of cannabis-related hyperemesis: A study design. The Network of Alcohol and other Drugs Agencies (NADA) Conference: Enhancing connections 2021.

Ravulo J, Woods D, Barrie L, Abdo J: The perceptions and impacts of drug and alcohol in Middle Eastern and Burmese communities: unveiling existing barriers in service-access and fostering stronger relationships through community engagement. The Network of Alcohol and other Drugs Agencies (NADA) Conference: Enhancing connections 2021.

*Woods D, Krizanac J: 2021: Enhancing CALD community outcomes: a co-design approach. The Network of Alcohol and other Drugs Agencies (NADA) Conference: Enhancing connections 2021.

Graf C (2020). Knowledge, injecting practice and experience of using performance and image enhancing drugs among clients of a Needle and Syringe Program in Australia: A qualitative interview study. Human Enhancement Drugs Network (HEDN) Symposium. Parramatta campus, University of New England.

Stratten M (2020). International students connecting with a sexual health and relationships information kit. 31st ISANA Conference.

Black E, Deacon RM, Mills L, Dunlop AJ, Ezard N, Bruno R, Shakeshaft A, Farrell M, Holmes J, Cretikos MA, Montebello M, Reid D, Childs S, Siefried K, Mammen K and Lintzeris N: Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants. Drug and Alcohol Review 2019, 38(S1):S27-S28.

Kelly PJ, Davis EL, Hinsley K, Deane FP, Buckingham M, Breeze D, Adams S: Exploring the landscape of client centred care in the treatment of substance dependence. Drug and Alcohol Review 2019, 38(S1):S61.

Larance B, Adams S (2019). Drawing on regional data analytics and stakeholder consultation to improve responses to methamphetamine-related harm in the Illawarra Shoalhaven region. NCCRED Annual Symposium 2019.

Mcketin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze PM, Carter G, Higgs P, Baker AL, Sinclair B, Reid D, Manning V, te Pas N, Liang W, Thomas T, Bathish R, Kent M, Raftery D, Arunogiri S, Cordaro F, Hill H and Berk M: A study protocol for the N‐ICE trial: a randomised double‐blind placebo‐controlled study of the safety and efficacy of n‐acetyl‐cysteine as a pharmacotherapy for methamphetamine dependence. Drug and Alcohol Review 2019, 38(S1):S71.

Raftery DK, Kelly PJ, Deane FP, Mcketin R, Baker AL, Ingram I, Goh MCW, Lubman DI, Carter G, Turner A, Dean O and Sinclair B: Insights into insight: a systematic review of insight in substance use disorders. Drug and Alcohol Review 2019, 38(S1):S84-S85

*Qian S, Song T, Yu P. A Study Design to Model Clinical Management Process for the Health and Wellbeing of Patients with Alcohol Use Disorders. Studies in health technology and informatics. 2019;264:1753-1754. 

*Qian S, Munyisia E, Yu P, Hailey D, Reid D: Precision of eMR data: the case for a drug and alcohol service. In: Stud Health Technol Inform. Volume 245, edn. Edited by Gundlapalli AV, Jaulent M-C, Zhao D. Hangzhou, China: IOS Press; 2017: 1118 - 1122.